On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

Listen Live Now » 1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
53° Feels Like: 53°
Wind: ENE 21 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 44°

Tomorrow

Partly Cloudy 60°

Fri Night

Mostly Clear 44°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

UCB says U.S. FDA committee recommends its drug Cimzia for new uses

BRUSSELS (Reuters) - Belgian pharmaceutical group UCB SA said a committee of the U.S. Food and Drug Administration voted in favor of allowing UCB's arthritis drug Cimzia to be used to treat adults with active axial spondyloarthritis.

While the vote was not binding on a final recommendation, it would play a part in the decision to clear the drug for this application in the United States, UCB said.

Axial spondyloarthritis is an inflammatory disease mostly affecting the spine and the pelvis.

(Reporting by Robert-Jan Bartunek; Editing by Matt Driskill)

Comments